Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia

NCT00313079 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Lymphocytic
Leukemia
Acute Lymphocytic Leukemia

Interventions

DRUG: MAb 216
DRUG: Vincristine

Sponsor

Steven E. Coutre